🔎 Trials Near Me

Beranda › PPOK › Michigan

Uji klinis PPOK di Michigan

22 studi untuk PPOK mencari peserta di lokasi di Michigan.

Kota di Michigan

Teks studi resmi (Bahasa Inggris)

WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

  • University of Michigan Medical Center, Ann Arbor
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07558265

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

  • Vitalis Clinical Research Center- Site Number : 8400040, Allen Park
  • Bolt Clinical Research- Site Number : 8400086, Brighton
  • Henry Ford Hospital- Site Number : 8400058, Detroit
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07190222

A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)

  • Revive Research Institute, Inc., Southfield
Menerima pesertaFase 2
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07759245

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

  • University of Michigan Health System - Ann Arbor- Site Number : 8400090, Ann Arbor
  • Veritas Clinical Research- Site Number : 8400007, Madison Heights
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

  • Henry Ford Hospital, Detroit
Menerima peserta
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 17 Sep 2026 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

  • Research Site, Farmington Hills
  • Research Site, Garden City
  • Research Site, Grand Rapids
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07082738

Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD

  • University of Michigan, Ann Arbor
  • Henry Ford Health, Detroit
Menerima pesertaFase 2
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07059091

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)

  • Research Site, Ann Arbor
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06878261

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

  • Research Site, Farmington Hills
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

  • Revival Research Institute, LLC, Dearborn
  • AA Medical Research Center, Flint
  • Revive Research Institute, Inc., Southfield
  • dan 1 lainnya
Menerima pesertaFase 2/3
Usia 35 hingga 80 · Semua jenis kelamin · Diperbarui 31 Agu 2026 · NCT07363694

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

  • Research Site, Ann Arbor
  • Research Site, Flint
  • Research Site, Southfield
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06283966

Multi-Center Clean Air Randomized Controlled Trial in COPD

  • University of Michigan, Ann Arbor
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 31 Jul 2026 · NCT06376994

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

  • GSK Investigational Site, Allen Park
  • GSK Investigational Site, Clarkston
  • GSK Investigational Site, Dearborn
Menerima pesertaFase 3
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 28 Jul 2026 · NCT07177339

Impact of Positive Airway Pressure Therapy on Clinical Outcomes in Older Veterans With Chronic Obstructive Pulmonary Disease and Comorbid Obstructive Sleep Apnea (Overlap Syndrome)

  • John D. Dingell VA Medical Center, Detroit, MI, Detroit
Menerima peserta
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 5 Jun 2026 · NCT04179981

SPIROMICS Study of Early COPD Progression (SOURCE)

  • University of Michigan, Ann Arbor
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 30 hingga 55 · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05033990

Neurocognitive and Health Impact of Sleep Apnea in Elderly Veterans With Comorbid COPD

  • John D. Dingell VA Medical Center, Detroit, MI, Detroit
Menerima peserta
Usia 60 hingga 89 · Semua jenis kelamin · Diperbarui 26 Mei 2026 · NCT02703207

Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD

  • Henry Ford Hospital - Lung and Pulmonary Care, Detroit
Menerima peserta
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 28 Apr 2026 · NCT07051707

Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3

  • University of Michigan, Ann Arbor
Menerima peserta
Usia 40 hingga 84 · Semua jenis kelamin · Diperbarui 24 Apr 2026 · NCT06891755

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

  • GSK Investigational Site, Allen Park
  • GSK Investigational Site, Detroit
  • GSK Investigational Site, Garden City
  • dan 1 lainnya
Menerima pesertaFase 3
Usia 40 hingga 80 · Semua jenis kelamin · Diperbarui 9 Apr 2026 · NCT06961214

University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2

  • University of Michigan, Ann Arbor
Menerima pesertaStudi observasional
Usia 50 hingga 80 · Semua jenis kelamin · Diperbarui 25 Mar 2026 · NCT07482475

Supporting Evidence-based Responses to Emotional Needs in Emphysema

  • Henry Ford Health System, Detroit
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jan 2026 · NCT06600126

myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • Henry Ford Health, Detroit
Menerima peserta
Usia 30 ke atas · Semua jenis kelamin · Diperbarui 6 Feb 2025 · NCT05204888

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.